share_log

BRIEF-Cybin Acquires Dmt Clinical Study From Entheon Biomedical

BRIEF-Cybin Acquires Dmt Clinical Study From Entheon Biomedical

簡介-Cybin從Entheon Biomedical公司獲得DMT臨牀研究
reuters ·  2022/06/07 21:05

June 7 (Reuters) - Cybin Inc CYBN.NLB :

路透6月7日電-Cybin Inc CYBN.NLB:

* CYBIN ACQUIRES DMT CLINICAL STUDY FROM ENTHEON BIOMEDICAL

*CyBIN從ENTHEON BioMedicine收購DMT臨牀研究

* CYBIN INC- PURCHASE PRICE OF ACQUISITION IS $1,000,000 (CAD)

*CyBIN Inc.-收購的購買價為1,000,000美元(加元)

Source text for Eikon: ID:nBw20D4Bma Further company coverage: CYBN.NLB

Eikon的源文本:ID:nBw20D4Bma進一步的公司報道:CYBN.NLB

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論